J01XA05 · Anti-infectives for systemic use
Tenkasi (previously Orbactiv)
Indications
Tenkasi is indicated for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults and paediatric patients aged 3 months and older (see sections 4.2, 4.4 and 5.1). Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Composition
- Active substance
- oritavancin (diphosphate)
- International name (INN)
- oritavancin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Tenkasi (previously Orbactiv)
- Active substance
- oritavancin (diphosphate)
- ATC code
- J01XA05
- Therapeutic area
- Soft Tissue Infections, Skin Diseases, Bacterial